Company Development 2013-2017

  • 2016

    Attracted Series A funding, recruited management team and identified drug and biomarker development partners.

  • 2015/2016

    Filed patent on biomarker and identified direct link with Alzheimer's.

  • 2014

    Attracted angel funding, recruited scientific team and established own labs.

  • 2013

    Filed patent application on chemical composition of matter for neuro-protection.

  • 2013

    Formed the company and attracted initial seed investment.